Source: International Congress 2019 – Biology of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
J. Heo (Chuncheon, Republic of Korea), Y. Heo (Chuncheon, Republic of Korea), Y. Hong (Chuncheon, Republic of Korea), S. Han (Chuncheon, Republic of Korea), H. Cheong (Seoul, Republic of Korea), W. Kim (Chuncheon, Republic of Korea). Difference of Copy number variation in the blood between patients with lung cancer and control. 3659

Member's Comments

No comment yet.

Related content which might interest you: Analysis and comparison of the transcriptome of COPD patients with and without lung cancer Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Analysis of the patients with primary lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 562s Year: 2007 Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function Source: Eur Respir J 2006; 28: Suppl. 50, 278s Year: 2006 Genetic variations and lung function Source: Eur Respir J 2006; 28: Suppl. 50, 525s Year: 2006 RARβ2 methylation level in blood for lung cancer assessment Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Analysis of 138 primary lung cancer cases Source: Eur Respir J 2006; 28: Suppl. 50, 73s Year: 2006 Absolute neutrophil count in peripheral blood predict prognosis in lung cancer patients treated with anlotinib Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Response shift in individual quality of life in patients with lung cancer Source: Annual Congress 2003 - Advanced lung cancer treatment Year: 2003 Evaluation of promoter hypermethylation in tissue and blood of non-small cell lung cancer patients and association with survival. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Association between young age and genomic alterations in never-smoker patients with non–small cell lung cancer Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Accuracy of the calculated estimated postoperative pulmonary function (CEPPF) in lung cancer patients Source: Annual Congress 2007 - Prognosis and diagnosis of thoracic malignancies Year: 2007 Analysis of the clinical feature of 383 patients with lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Tele-cancer: Reducing time-to-treatment for patients with lung cancer Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 Comparison of two methods for estimating the predicted postoperative (PPO) lung function after lung cancer resection in COPD patients Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Small cell lung cancer patients and their responses to treatment Source: Eur Respir J 2004; 24: Suppl. 48, 301s Year: 2004 Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Resectable proportion of lung cancers in an unselected population Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008